Safety of HIF prolyl hydroxylase inhibitors for anemia in dialysis patients: a systematic review and network meta-analysis

Aim: We performed a systematic review and network meta-analysis evaluating the safety and efficacy of hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) among dialysis chronic kidney disease patients. Methods: Safety was evaluated with any adverse events (AEs), serious adverse events...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Dinghua, Niu, Yue, Liu, Fei, Yang, Yue, Wang, Xue, Li, Ping, Chen, Xiangmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244523/
https://www.ncbi.nlm.nih.gov/pubmed/37292157
http://dx.doi.org/10.3389/fphar.2023.1163908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244523/
https://www.ncbi.nlm.nih.gov/pubmed/37292157
http://dx.doi.org/10.3389/fphar.2023.1163908

Ejemplares similares